← FDA Drug Approvals (Drugs@FDA)

ZENBEXUS

NDA · New Drug Application · Sponsor: BRISTOL MYERS SQUIBB · Approved 2026-08-13

Drug application

FDA Application #

NDA221075

Application type

New Drug Application

Brand name

ZENBEXUS

Generic name

IBERDOMIDE

Active ingredients

IBERDOMIDE HYDROCHLORIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

BRISTOL MYERS SQUIBB

Manufacturer

E.R. Squibb & Sons, L.L.C.

First approval

2026-08-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown